AI Article Synopsis
Article Abstract
Background: Gemella genus bacteria can produce localized or generalized severe infections, but very rarely they have been described as causing pulmonary infections or pleural empyemas.
Aim: To characterize patients with empyema caused by Gemella genus bacteria.
Material And Methods: The database of a Microbiology laboratory of a Spanish hospital was reviewed, searching for Gemella positive cultures of pleural effusions in a period of five years.
Results: We identified 12 patients (11 males) with Gemella spp pleural empyema. Eight were infected with G. haemolysans and four with G. morbillorum. All patients had predisposing factors such as poor oral hygiene, smoking, chronic cardiovascular or respiratory disease, alcoholism or malignancies. In ten cases, a thoracic drainage tube was placed with fibrinolysis in seven. One patient needed surgery because of a relapse of the empyema. Two patients died because of an advanced neoplasm, and the empyema was resolved in the rest.
Conclusions: Gemella pleural empyema can occur and its isolation must not be seen as a contamination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4067/S0034-98872012001200004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Meningitis due to Gemella sp. in a patient with severe ENT conditions: case report and review of the literature.
Ann Clin Microbiol Antimicrob
December 2024
Laboratoire de Microbiologie, Centre Hospitalier de Valenciennes, Valenciennes, F-59300, France.
In June 2022, a 73-year-old man with a history of laryngeal and esophageal carcinoma was admitted to the emergency unit with sudden fever, confusion, and general condition deterioration. Initial assessments showed a fever of 38.5 °C, elevated C-reactive protein (CRP) at 209 mg/L, and a neutrophil count of 10.
View Article and Find Full Text PDFLinking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.
Biomedicines
October 2024
Primary Immunodeficiencies Unit, Department of Internal Medicine, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
Article Synopsis
- Common variable immunodeficiency (CVID) is characterized by low immunoglobulin levels and recurrent infections; up to 30% of patients experience granulomatous-lymphocytic interstitial lung disease (GLILD) as a non-infectious complication.
- A study analyzed the microbiomes of salivary, sputum, and fecal samples from CVID patients with GLILD and compared them to those without GLILD and healthy controls, revealing lower biodiversity in GLILD patients.
- The findings suggest significant alterations in the microbiome of GLILD patients that may be linked to both local and systemic immune dysregulation, highlighting a potential relationship between these microbiome changes and the disease.
Background And Purpose: Despite substantial evidence supporting the role of resident bacterial communities in therapeutic fasting outcomes, research has primarily focused on gut microbiota, leaving changes in oral microbiota largely unexplored. The clinical significance of oral health changes during fasting is nonetheless underscored by the documented development of halitosis in fasting individuals. However, no scientific studies have comprehensively examined the interplay between salivary microbiota alterations, inflammatory changes in the gingival crevice, and the production of malodorous volatile compounds.
View Article and Find Full Text PDFDynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis.
Ann Clin Microbiol Antimicrob
September 2024
State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis Research, Department of Tuberculosis Internal Medicine, Guangzhou Chest Hospital, Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, Guangdong, 510095, P.R. China.
Background: Respiratory microbiota is closely related to tuberculosis (TB) initiation and progression. However, the dynamic changes of respiratory microbiota during treatment and its association with TB progression remains unclear.
Methods: A total of 16 healthy individuals and 16 TB patients (10 drug-sensitive TB (DS-TB) and 6 drug-resistant TB (DR-TB)) were recruited.
Changes in the pharyngeal and nasal microbiota in pediatric patients with adenotonsillar hypertrophy.
Microbiol Spectr
October 2024
Unit of Microbiomics and Research Unit of Microbiome, IRCCS, Bambino Gesù Children's Hospital, Rome, Italy.
Unlabelled: The present study aimed to investigate the pharyngeal and nasal microbiota composition in children with adenotonsillar hypertrophy (AH) and assess longitudinal alterations in both microbiota after a probiotic oral spray treatment. A cohort of 57 AH patients were enrolled and randomly assigned to the probiotic and placebo groups for a 5-month treatment course. Pharyngeal and nasal swabs were collected before and after treatment and analyzed by 16S rRNA-based metataxonomics and axenic cultures for pathobiont identification.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!